Boxer Capital, LLC Rigel Pharmaceuticals Inc Transaction History

Boxer Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$2.08 - $3.36 $4.83 Million - $7.8 Million	-2,321,900 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$2.83 - $4.11 $7.98 Million - $11.6 Million	-2,818,100 Reduced 54.83%	2,321,900 $6.57 Million
Q1 2018 May 15, 2018	BUY	$3.54 - $4.54 $7.08 Million - $9.08 Million	2,000,000 Added 63.69%	5,140,000 $18.2 Million
Q4 2017 Feb 14, 2018	BUY	$3.23 - $4.3 $10.1 Million - $13.5 Million	3,140,000	3,140,000 $12.2 Million

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $4.17B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.